Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,941 | 217 | 820 | 0 | 0 |
| Receivables | 1,263 | 1,125 | 851 | 0 | 0 |
| Other current assets | 709 | 599 | 489 | 0 | 0 |
| TOTAL | $3,913 | $1,940 | $2,160 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 856 | 899 | 965 | N/A | N/A |
| Intangibles | 349 | 329 | 325 | 0 | 0 |
| Other Non-Current Assets | 1,337 | 4,242 | 5,502 | 0 | 0 |
| TOTAL | $2,543 | $5,470 | $6,792 | $N/A | $N/A |
| Total Assets | $6,456 | $7,411 | $8,952 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,997 | 2,990 | 2,871 | 0 | 0 |
| Accounts payable and accrued liabilities | 2,743 | 4,885 | 4,579 | 0 | 0 |
| TOTAL | $12,639 | $13,102 | $11,772 | $0 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 8,149 | 8,441 | 0 | 0 |
| Deferred Revenues | 319 | 676 | 468 | N/A | N/A |
| Other Non-Current Liabilities | 518 | 7,518 | 12,549 | 0 | 0 |
| TOTAL | $686 | $15,832 | $21,162 | $N/A | $N/A |
| Total Liabilities | $13,324 | $28,935 | $32,933 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29 | 29 | N/A | N/A | N/A |
| Retained earnings | -55,734 | -46,592 | -48,935 | 0 | 0 |
| Other shareholders' equity | 0 | 0 | -17 | 0 | 0 |
| TOTAL | $-6,869 | $-21,524 | $-23,981 | $0 | $0 |
| Total Liabilities And Equity | $6,456 | $7,411 | $8,952 | $0 | $0 |